Report Back From ASCO 2024: What’s the Latest in HR+ MBC?
Living with MBC, Diagnosis and Treatment, Clinical Research, Research, ASCO Our MBClife Living with MBC, Diagnosis and Treatment, Clinical Research, Research, ASCO Our MBClife

Report Back From ASCO 2024: What’s the Latest in HR+ MBC?

We are thrilled to present an audio version of SHARE Cancer Support’s webinar “Report Back from ASCO 2024: Latest Updates on HR+ Metastatic Breast Cancer (MBC)”.

This episode is an in-depth report from the ASCO 2024 Annual Meeting, featuring the latest advancements and research in HR+ MBC. Hear from Dr. Kevin Kalinsky as we dive into the findings from the DESTINY-Breast06 and postMONARCH trials, exploring their implications and potential impact on treatment strategies.

Read More
Road to a Cure - Dr. Sara Hurvitz
Novel Treatments, Medical Community, Challenges and Barriers, Clinical Research, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, Clinical Research, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat Our MBClife

Road to a Cure - Dr. Sara Hurvitz

The Road to a Cure series gets on the redeye to LA to have Senior Producer and Co-host, Victoria Goldberg and co-host Kate Pfitzer speak with Dr. Sara Hurvitz. She talks about her perspective on where we are as we work for a cure, the HER2+ studies she is excited about, and other research that is intriguing as it relates to all subtypes

Read More
Report Back from ASCO: What’s the Latest in Metastatic Breast Cancer
Novel Treatments, Medical Community, Clinical Research, Entities of Cancer, Updates from Conferences, Difficult to Treat, Obstacles to Better Outcomes Our MBClife Novel Treatments, Medical Community, Clinical Research, Entities of Cancer, Updates from Conferences, Difficult to Treat, Obstacles to Better Outcomes Our MBClife

Report Back from ASCO: What’s the Latest in Metastatic Breast Cancer

Are you living with ER+/HER2- or TNBC MBC and tired of hearing about new HER2 therapies and wondering when it will be your turn? Just after the meeting SHARE welcomed Dr. Timothy Pluard from University of Missouri-KC School of Medicine to a webinar highlighting promising data from trials and labs across the globe presented at the this year’s meeting,

Read More
Report back from SABCS
Medical Community, Clinical Research, Lifestyle Research, Diagnosis and Treatment, Updates from Conferences, Entities of Cancer, Novel Treatments, Obstacles to Better Outcomes, Difficult to Treat, MBC Imaging and Profiling Our MBClife Medical Community, Clinical Research, Lifestyle Research, Diagnosis and Treatment, Updates from Conferences, Entities of Cancer, Novel Treatments, Obstacles to Better Outcomes, Difficult to Treat, MBC Imaging and Profiling Our MBClife

Report back from SABCS

Welcome to this bonus episode of Our MBC Life. It feels like a lifetime ago, but just a few weeks ago the world's largest breast cancer conference, the San Antonio Breast Cancer Symposium, was held. Just after the symposium SHARE welcomed Dr. Neil Iyengar from Memorial Sloan Kettering to a webinar where he shared information from SABCS highlighting both early-stage and metastatic research.

Read More
Nancy U. Lin, MD
Medical Community, Novel Treatments, Essential Knowledge, Diagnosis and Treatment, Challenges and Barriers, Obstacles to Better Outcomes, Clinical Research, Difficult to Treat, MBC Imaging and Profiling, Entities of Cancer Our MBClife Medical Community, Novel Treatments, Essential Knowledge, Diagnosis and Treatment, Challenges and Barriers, Obstacles to Better Outcomes, Clinical Research, Difficult to Treat, MBC Imaging and Profiling, Entities of Cancer Our MBClife

Nancy U. Lin, MD

A conversation with Dr. Nancy Lin, Director of the Metastatic Breast Cancer Program at Dana-Farber Cancer Institute.

Read More